Cresco Labs Inc.
Data quality: 100%
CRLBF
OTC
Manufacturing
Chemicals
$0.96
▲
$0.06
(6.77%)
Mkt Cap: 345.87 M
Price
$0.96
Mkt Cap
345.87 M
Day Range
$0.95 — $0.99
52-Week Range
$0.43 — $2.30
Volume
34,458
Open $0.95
50D / 200D Avg
$1.00
3.61% below
50D / 200D Avg
$1.01
5.21% below
Quick Summary
Key Takeaways
Generating 37.75 M in free cash flow
Capital efficient — spends only 5.36% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-9.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-33.22%
Above sector avg (-53.41%)
ROIC-1.86%
Net Margin-20.65%
Op. Margin-4.27%
Safety
Debt / Equity
1.26
Above sector avg (0.31)
Current Ratio2.59
Interest Coverage-0.67
Valuation
PE (TTM)
-2.55
Below sector avg (-1.48)
P/B Ratio1.02
EV/EBITDA34.54
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.6 | -1.5 |
| P/B | 1.0 | 1.6 |
| ROE % | -33.2 | -53.4 |
| Net Margin % | -20.7 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | 1.3 | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -9.46% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 655.85 M | Net Income (TTM) | -135.41 M |
| ROE | -33.22% | ROA | -10.61% |
| Gross Margin | 49.49% | Operating Margin | -4.27% |
| Net Margin | -20.65% | Free Cash Flow (TTM) | 37.75 M |
| ROIC | -1.86% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.26 | Current Ratio | 2.59 |
| Interest Coverage | -0.67 | Asset Turnover | 0.51 |
| Working Capital | 159.09 M | Tangible Book Value | -143.07 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.55 | Forward P/E | N/A |
| P/B Ratio | 1.02 | P/S Ratio | 0.53 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 34.54 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 10.92% | ||
| Market Cap | 345.87 M | Enterprise Value | 715.85 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.38 | Revenue / Share | 1.82 |
| FCF / Share | 0.11 | OCF / Share | 0.20 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 5.36% | FCF Conversion | -27.88% |
| SBC-Adj. FCF | 26.52 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 655.85 M | 724.34 M |
| Net Income | -135.41 M | -74.44 M |
| EPS (Diluted) | -0.38 | -0.22 |
| Gross Profit | 324.57 M | 364.45 M |
| Operating Income | -27.99 M | 107.29 M |
| EBITDA | — | — |
| R&D Expenses | — | — |
| SG&A Expenses | 247.45 M | 254.84 M |
| D&A | 48.71 M | 59.10 M |
| Interest Expense | 41.75 M | 37.93 M |
| Income Tax | 44.62 M | 49.87 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 1.20 B | 1.36 B |
| Total Liabilities | 944.80 M | 967.18 M |
| Shareholders' Equity | 340.45 M | 474.85 M |
| Total Debt | 427.88 M | 472.68 M |
| Cash & Equivalents | 57.90 M | 137.56 M |
| Current Assets | 259.27 M | 294.26 M |
| Current Liabilities | 100.18 M | 94.34 M |
{"event":"ticker_viewed","properties":{"ticker":"CRLBF","listing_kind":"stock","pathname":"/stocks/crlbf","exchange":"OTC","country":"US"}}